Published in
Springer, Neurology and Therapy, 1(11), p. 459-469, 2022
DOI: 10.1007/s40120-021-00317-5
Links
Tools
Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment
Journal article published in 2022 by
Robert A. Hauser 
,
Antonella Favit,
L. Arthur Hewitt,
Annika Lindsten,
Stephen Gorny,
Steven Kymes,
Stuart H. Isaacson
,
Antonella Favit,
L. Arthur Hewitt,
Annika Lindsten,
Stephen Gorny,
Steven Kymes,
Stuart H. Isaacson
This paper is made freely available by the publisher.
Full text: Download
Data provided by 